Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 3
1969 1
1970 2
1971 1
1972 1
1975 3
1977 2
1978 1
1980 2
1983 1
1984 2
1985 2
1986 3
1987 6
1988 7
1989 3
1990 1
1991 7
1992 4
1993 10
1994 2
1995 3
1996 4
1997 6
1998 3
1999 1
2000 5
2001 2
2002 3
2003 3
2004 5
2005 2
2006 2
2007 2
2008 3
2009 2
2010 5
2011 8
2012 5
2013 2
2014 6
2015 7
2016 6
2017 4
2018 2
2019 1
2021 1
2022 3
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma.
Lozano AX, Chaudhuri AA, Nene A, Bacchiocchi A, Earland N, Vesely MD, Usmani A, Turner BE, Steen CB, Luca BA, Badri T, Gulati GS, Vahid MR, Khameneh F, Harris PK, Chen DY, Dhodapkar K, Sznol M, Halaban R, Newman AM. Lozano AX, et al. Among authors: halaban r. Nat Med. 2022 Feb;28(2):353-362. doi: 10.1038/s41591-021-01623-z. Epub 2022 Jan 13. Nat Med. 2022. PMID: 35027754 Free PMC article.
Interferon-stimulated neutrophils as a predictor of immunotherapy response.
Benguigui M, Cooper TJ, Kalkar P, Schif-Zuck S, Halaban R, Bacchiocchi A, Kamer I, Deo A, Manobla B, Menachem R, Haj-Shomaly J, Vorontsova A, Raviv Z, Buxbaum C, Christopoulos P, Bar J, Lotem M, Sznol M, Ariel A, Shen-Orr SS, Shaked Y. Benguigui M, et al. Among authors: halaban r. Cancer Cell. 2024 Feb 12;42(2):253-265.e12. doi: 10.1016/j.ccell.2023.12.005. Epub 2024 Jan 4. Cancer Cell. 2024. PMID: 38181798 Free PMC article.
CD4 T cells and toxicity from immune checkpoint blockade.
Earland N, Zhang W, Usmani A, Nene A, Bacchiocchi A, Chen DY, Sznol M, Halaban R, Chaudhuri AA, Newman AM. Earland N, et al. Among authors: halaban r. Immunol Rev. 2023 Sep;318(1):96-109. doi: 10.1111/imr.13248. Epub 2023 Jul 25. Immunol Rev. 2023. PMID: 37491734 Review.
RASopathy Gene Mutations in Melanoma.
Halaban R, Krauthammer M. Halaban R, et al. J Invest Dermatol. 2016 Sep;136(9):1755-1759. doi: 10.1016/j.jid.2016.05.095. Epub 2016 May 25. J Invest Dermatol. 2016. PMID: 27236105 Free PMC article. Review.
RAC1 and melanoma.
Halaban R. Halaban R. Clin Ther. 2015 Mar 1;37(3):682-5. doi: 10.1016/j.clinthera.2014.10.027. Epub 2014 Nov 22. Clin Ther. 2015. PMID: 25465943 Free PMC article.
Meenhard Herlyn.
Halaban R. Halaban R. Pigment Cell Melanoma Res. 2010 Apr;23(2):287. doi: 10.1111/j.1755-148X.2010.00683.x. Pigment Cell Melanoma Res. 2010. PMID: 20394680 No abstract available.
A novel anti-melanoma SRC-family kinase inhibitor.
Halaban R, Bacchiocchi A, Straub R, Cao J, Sznol M, Narayan D, Allam A, Krauthammer M, Mansour TS. Halaban R, et al. Oncotarget. 2019 Mar 19;10(23):2237-2251. doi: 10.18632/oncotarget.26787. eCollection 2019 Mar 19. Oncotarget. 2019. PMID: 31040916 Free PMC article.
Fibroblast growth factors in normal and malignant melanocytes.
Halaban R, Funasaka Y, Lee P, Rubin J, Ron D, Birnbaum D. Halaban R, et al. Ann N Y Acad Sci. 1991;638:232-43. doi: 10.1111/j.1749-6632.1991.tb49034.x. Ann N Y Acad Sci. 1991. PMID: 1723854 Review. No abstract available.
160 results